TD Asset Management’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22M | Buy |
21,278
+12,294
| +137% | +$1.28M | ﹤0.01% | 906 |
|
|
2025
Q1 | $1.05M | Buy |
+8,984
| New | +$1.05M | ﹤0.01% | 1067 |
|
|
2024
Q1 | – | Sell |
-16,000
| Closed | -$1.27M | – | 1389 |
|
|
2023
Q4 | $1.27M | Buy |
+16,000
| New | +$1.27M | ﹤0.01% | 1125 |
|
|
2021
Q3 | – | Sell |
-35,116
| Closed | -$1.71M | – | 1528 |
|
|
2021
Q2 | $1.71M | Buy |
35,116
+8,800
| +33% | +$428K | ﹤0.01% | 1138 |
|
|
2021
Q1 | $1.49M | Sell |
26,316
-2,500
| -9% | -$142K | ﹤0.01% | 1173 |
|
|
2020
Q4 | $2.35M | Buy |
28,816
+3,200
| +12% | +$261K | ﹤0.01% | 996 |
|
|
2020
Q3 | $1.83M | Hold |
25,616
| – | – | ﹤0.01% | 934 |
|
|
2020
Q2 | $2.11M | Buy |
25,616
+8,600
| +51% | +$708K | ﹤0.01% | 867 |
|
|
2020
Q1 | $1M | Sell |
17,016
-22,400
| -57% | -$1.32M | ﹤0.01% | 996 |
|
|
2019
Q4 | $4.07M | Buy |
39,416
+3,216
| +9% | +$332K | 0.01% | 763 |
|
|
2019
Q3 | $733K | Buy |
36,200
+9,700
| +37% | +$196K | ﹤0.01% | 1113 |
|
|
2019
Q2 | $682K | Buy |
+26,500
| New | +$682K | ﹤0.01% | 1125 |
|